Share Name Share Symbol Market Type Share ISIN Share Description
Stm Group Plc LSE:STM London Ordinary Share IM00B1S9KY98 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 34.00 7,979 08:00:00
Bid Price Offer Price High Price Low Price Open Price
33.00 35.00 34.00 34.00 34.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 23.98 2.02 2.70 12.6 20
Last Trade Time Trade Type Trade Size Trade Price Currency
11:44:00 O 6,979 33.25 GBX

Stm (STM) Latest News

More Stm News
Stm Investors    Stm Takeover Rumours

Stm (STM) Discussions and Chat

Stm Forums and Chat

Date Time Title Posts
29/5/202118:12STM Group1,163
09/1/200919:12Streetnames with Charts & News9
14/7/200509:52Streetnames - an interesting shell47

Add a New Thread

Stm (STM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-06-15 10:44:0133.256,9792,320.52O
2021-06-15 10:38:2333.251,000332.50O
View all Stm trades in real-time

Stm (STM) Top Chat Posts

Stm Daily Update: Stm Group Plc is listed in the General Financial sector of the London Stock Exchange with ticker STM. The last closing price for Stm was 34p.
Stm Group Plc has a 4 week average price of 31.70p and a 12 week average price of 28.50p.
The 1 year high share price is 41p while the 1 year low share price is currently 25.50p.
There are currently 59,408,087 shares in issue and the average daily traded volume is 40,535 shares. The market capitalisation of Stm Group Plc is £20,198,749.58.
smithie6: interesting although I think that STM will make acquisition(s) in 2021, as the MD stated in the recent presentation. & imo the sale of 2 companies was to produce cash to help fund acquisition(s) Release of regulatory cash if STM is bought. Not 100% true. All depends on the acquisition price, & it would be the acquisition cash that shareholders would receive, not the regulatory cash; but yes any acquisition price would, of course, very much take in to account the cash obtained. The acquirer would probably want some of that regulatory cash, to at least cover the regulations on the acquisition day, but one assumes that the amount of reqd regulatory cash would then reduce over time as the acquirer reduced the total staff & operating costs. (for some assets the amount of regulatory cash reqd. is related to the value of the assets held, so no cash would be released for that part of an acquisition of STM, imo) ----- whatever happens I think that all the dirs & ex-dirs & related parties (who own a fair % of STM) would want the share price of STM to be higher if it were to be acquired by someone. The MD has just seen 3 IT projects go live, so I'm sure he will want those to produce some results/savings rather than throw in the towel one week later. & with better IT & with auto enrollment the co. has much better capabilities now to grow, 'if' it can generate the new client applications or via acquisitions.
camerongd53: There has been much talk of STM being a consolidator in the fragmented SIPP market. If STM pursue this, I am happy if it is for the benefit of the share price as STM has been strategically restructured to achieve this With the streamlining of the group and disposal of non-core activities. I ask is STM being set up to be consolidated rather than as a consolidator. The FD Therese Neish is leaving and has a shareholding of approx. 500k. Selling out for up to 100p per share would be very convenient for her finances!! I am sure the other shareholders would accept such an offer. Such an offer would release the statutory capital balances to current shareholders. The cash balances cannot be distributed as dividends for operational reasons. Just wondering I think the conolidation process which ever way it goes is unfortunately on hold until the historical Carey issue is finally resolved.
smithie6: interesting share price movement looks like the trades are virtually all sell trades but the price to sell is up 2p !, inferring imo that there is a buy trade(s) being filled that we don't know about yet, or some buy trades have gone thru on another market which are not shown on the advfn info for trades :-)
smithie6: I liked the presentation. btw it has been recorded, & the slides & the Q&A at the end, so anyone still doing a 9 to 5 can listen to it this evening. it will be interesting to see if any increase to expected profit for 2021 is made in any broker analysis (which I think means just Finncap) & the answer to that is probably no. although it was confirmed, as expected, that Carey is now moving in to profit as expected & the savings from using more in-house software are starting to happen, also as expected, so these things should already be in any analyst's prediction. ---- I was interested to hear that one of the software developments produces a saving by not paying license fees for the industry std. software. (I hadn't realised that). The MD said that 2 software developments are now in use & the 3rd one (the final main sw project I think) is going live this month or at the start of next month. That's good. I was surprised that the co. is using external consultants to advise on how to reduce the regulatory capital. I thought the co. had been operating for years & hence knew the reqts inside out, so I'm surprised they need to pay for someone outside the co. to help them ! (they are looking at phps putting 2 'life' cos. in Gib. together. I think someone posted about that in recent days) Also surprised that the MD spends >= 50% of his time in Gibraltar. imo all the acquisitions & integration & cost reduction work & relocation to Milton Keynes is in the UK !! & surely he should be directing all of that. (& I assume software development, the MDs specialist area, he was previously the tech./IT dir. of STM) & not in Gibraltar. & the job of the new FD is advertised as UK based. (so time spent in Gib., is it just because that is where the MD has lived for 20-25 years & his friends & family & life is there, rather than it phps being what STM really needs ?) is the UK part wandering without leadership ? (phps under the leadership of the seller of the Carey business ??) the MD & FD came over well. both seemed to be educated intelligent capable people, as you would expect/hope (but which is not fulfilled at many listed companies !; at STX for example the MD doesn't present well (& the same was true for the previous MD of Bluestar, who appeared a bit bored & tired in financial studio interviews !, ok he was !, je je) the MD chatted a little about co. valuation in the Q&A, & feels that the share price is undervalued, especially based on the EV (after subtracting the nett cash from the cap. value) & in X years time he expects/hopes it will be higher future divi security was discussed & the MD said that some insti shareholders are income funds, that would not be happy if the divi was cut to put the money in to acquisitions, so, unlucky to be cut except for any shocks ......a lot more was discussed/presented but I don't think there was much that a close follower of STM didn't already know.
lundun42: Smithie6 - It says in the report "No new or incremental business can be accepted from the EU from 1 January 2021 until any new permissions are granted or equivalence is agreed. STM Life will continue administering its inforce EU policies to their natural conclusion (e.g. surrender, transfer out or policy maturity)." IIRC STM said a year or two ago that they were planning to move the STM Life company to Malta but that has not happened and they now seem to be intending to merge their two life companies in Gibraltar. I took the note to mean that they can't do new EU life assurance business so I can't see how anything can continue to come from Malta for the life company. Yes they have their large pensions business in Malta which should carry on unaffected by Brexit but surely the Gibraltar based insurance companies can't now take life business from Malta (or anywhere else in the EU)as they no longer have permissions to do so since Brexit happened. Also by mentioning "incremental business" the report seems to make clear that existing EU customers aren't allowed put more money into their policies either. Not good unless the equivalence thing soon gets sorted I suppose.
smithie6: RNS issued today web presentation this Thursday 20th May to review results , sale of 2 businesses & prospects. "Investor Presentation STM Group Plc (AIM: STM), the cross-border financial services provider, announces that the Chief Executive, Alan Kentish, and the Chief Financial Officer, Therese Neish, will be hosting a remote presentation to review the 2020 results, the sale of the Gibraltar and Jersey businesses, and prospects at 15:00 on Thursday 20 May. The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company and add to meet STM Group Plc via the following link hxxps://" . cut
smithie6: cash input from the sale at the end of March & this new sale ~ 2 million + 1.4 million = ~ £3.4 million (but ideally the £ 2 million value should be checked for cash held etc) about 5.6p/share, with share price of ~31p. a notable % of the cap. value of STM & a much bigger % increase in cash surplus to that for regulatory reqts. there is a lot more cash available for acquisitions or will be once all cash & stage payments are received.
smithie6: perhaps the Carey-Adams case increase the case for ppl to use authorised IFAs, with STM then administering the assets (STM administers a few billions !) & avoiding unauthorised advisers ----- phps STM will change its application forms to add "has any unauthorised person/body advised you to transfer your assets to STM ?" & reject any application that says "yes" or something along those lines :-(
smithie6: AFH (wealth management co. based in the midlands with 20,000 clients) has received an agreed takeover offer share price is up. is STM a takeover target ? ---- AFH looks to have revenue & PBT of about 3x that for STM but AFH has a cap. value of 195million, much higher than 3x the cap. value of STM (£18 Million. x3 =~ £54 million) clearly wealth management is much more highly valued than what STM does !!
smithie6: some data per share performance over recent years A) yr to Dec. '14. 2014. no. of shares 53 million & 63m diluted turnover = £15.9m per diluted share = 25.2p net cash £5.7m. per diluted share = 9p B) yr to Dec. '19 no. of shares 59.4 million & 60.4m diluted turnover = 23.3m per diluted share = 38.6p net cash £17.2 m. per diluted share = 28.5p ------ performance - turnover per share up by about 50% wrt 2014 (25.2p to 38.6p /diluted share) - net cash per share up from 9p/share to 28.5p/share (& if had retained cash paid out via divis it would be 28.5p+ ~7p = 35.5p !; from 9p to 35.5p cash/share in 6 years, impressive !) about x3 what it was !! & 28.5p/share is 75% of the share price, whereas it was perhaps 24% in 2014 (if take the share price as 38p, share price rose to 70p at which time the cash/share as a % was much lower of course) ----- at many small AIM cos. they keep raising money by issuing new shares...while the perf. data "per share" normally/often keeps falling at STM you can see that the number of shares is about the same in 2020 as it was at Dec 31 2014. So the various acquisitions made during the intervening years have all been basically/overall funded from profits !, improving the per share data. Excellent. ----- good numbers imo with the high cash /share surely giving good downside protection for the share price, coupled with the high recurring revenue ...hopefully the profit numbers will improve over the next 2 years as the BOD expects (with the share price following along)
Stm share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210616 02:12:27